Diabetes treatment is constantly advancing, with new therapeutic options emerging to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://alyshakeqm712436.wikiconverse.com/6084941/novel_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment